Gerald H. Mickisch
Robert Koch Str. 34a
Bremen, HB 28277, Germany
Bremen, HB 28277, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Immunotherapy and tyrosine kinase inhibitors in first-line treatment of metastatic renal cell carcinoma-Which strategy when?
Journal: Der Urologe. Ausg. A
Published: October 07, 2020
The European Medicines Agency approval of axitinib (Inlyta) for the treatment of advanced renal cell carcinoma after failure of prior treatment with sunitinib or a cytokine: summary of the scientific assessment of the committee for medicinal products for human use.
Journal: The oncologist
Published: January 25, 2015
Assessing the impact of evolving evidence in renal cell carcinoma treatment: an update of the Renal Cell Carcinoma Appropriateness-based Treatment Toolkit (ReCATT).
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 24, 2014
Metastatic castration-resistant prostate cancer: position paper for structured therapy monitoring
Journal: Der Urologe. Ausg. A
Published: May 09, 2014
Metastatic renal cell carcinoma: primary and follow-up treatment
Journal: Der Urologe. Ausg. A
Published: October 31, 2013
Treatment algorithm for metastatic renal cell carcinoma--recommendations based on evidence and clinical practice.
Journal: Oncology research and treatment
Published: September 30, 2013
A multinational phase II trial of bevacizumab with low-dose interferon-α2a as first-line treatment of metastatic renal cell carcinoma: BEVLiN.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: June 28, 2013
Evaluation of treatment options for patients with advanced renal cell carcinoma: assessment of appropriateness, using the validated semi-quantitative RAND corporation/University of California, Los Angeles methodology.
Journal: European journal of cancer (Oxford, England : 1990)
Published: February 15, 2012
Costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma: bevacizumab in combination with interferon-alpha2a compared with sunitinib.
Journal: British journal of cancer
Published: November 19, 2009
Combination of surgery and immunotherapy in metastatic renal cell carcinoma.
Journal: World journal of urology
Published: November 15, 2004
Last Updated: 09/26/2026